13 insiders have filed at GEN since 2023Q3: names, roles, reported stakes, and each person's buying and selling record from SEC Form 3/4/5 filings.
| name | role | reported stake | % of company | buys (3y) | sells (3y) |
|---|---|---|---|---|---|
| Baudis Pavel | Director | 49.85M | 8.066% | ||
| Feld Peter A | Director | 17.62M | 2.851% | 4 sells $26.8M | |
| Vlcek Ondrej | Director | 4.23M | 0.685% | 1 sells $3.1M | |
| Pilette Vincent | CEO, Pres. & Chair | 2.80M | 0.454% | 1 sells $4.6M | |
| Ko Bryan Seuk | COO, CLO And Secretary | 587.4k | 0.095% | 3 sells $2.8M | |
| Derse Natalie Marie | CFO | 456.7k | 0.074% | 4 sells $4.2M | |
| Dangeard Frank E | Director | 185.2k | 0.03% | ||
| Barsamian Sue | Director | 118.7k | 0.019% | ||
| Brandt Eric | Director | 97.4k | 0.016% | ||
| Smith Sherrese M | Director | 73.9k | 0.012% | ||
| Heath Emily | Director | 67.2k | 0.011% | ||
| Denzel Nora | Director | 43.7k | <0.01% | 1 sells $910k | |
| Chrystal John C | Director | 28.4k | <0.01% | 2 buys $457k |
Full register at boothcheck.com/insiders/GEN. Stakes are the newest reported Form 3/4/5 balances (they update only when insiders file). Sales counted include pre-scheduled plan sales, labeled. A filed record, not a forecast. Nothing here is investment advice.